Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The International Journal of Biochemistry & Cell Biology|July 23, 2016
Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell linesRadosſaw Januchowski, Karolina Wojtowicz, Karolina Sterzyſska, et al.
International Journal of Molecular Sciences|April 28, 2019
PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like PopulationsMonika Świerczewska, Karolina Sterzyńska, Karolina Wojtowicz, et al.
Oncotarget|November 2, 2017
The significance of lumican expression in ovarian cancer drug-resistant cell linesAndrzej Klejewski, Karolina Sterzyńska, Karolina Wojtowicz, et al.
International Journal of Molecular Sciences|August 16, 2019
Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell LinesKarolina Sterzyńska, Dominika Kaźmierczak, Andrzej Klejewski, et al.
International Journal of Molecular Sciences|September 28, 2018
The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell LinesKarolina Sterzyńska, Andrzej Klejewski, Karolina Wojtowicz, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 30, 2022
The significance of interferon gamma inducible protein 16 (IFI16) expression in drug resistant ovarian cancer cell linesJustyna Borucka, Karolina Sterzyńska, Dominika Kaźmierczak, et al.
Plos One|February 18, 2017
Expression and activity of multidrug resistance proteins in mature endothelial cells and their precursors: A challenging correlationAgnieszka Krawczenko, Aleksandra Bielawska-Pohl, Karolina Wojtowicz, et al.
International Journal of Molecular Sciences|December 26, 2018
Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance DevelopmentKarolina Sterzyńska, Andrzej Klejewski, Karolina Wojtowicz, et al.
Pageof 3